Axsome
FDA Approves AUVELITY — Axsome Therapeutics, Inc.
# FDA Approves Axsome Therapeutics' AUVELITY for Major Depressive Disorder Axsome Therapeutics received FDA approval for AUVELITY (dextromethorphan h...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Advagen
FDA Approves ACYCLOVIR — Advagen Pharma Limited
Advagen Pharma Limited received FDA approval on August 18, 2022, for the Abbreviated New Drug Application ANDA215724, finalizing its launch of the ora...
SYTA
Building Distribution: Is Siyata's Group Of Strategic Business Collaborators Ready To Impact The Push-To-Talk Market?
Building Distribution: Is Siyata's Group Of Strategic Business Collaborators Ready To Impact The Push-To-Talk Market?...
AstraZeneca
FDA Approves CALQUENCE — AstraZeneca Pharmaceuticals LP
# FDA Approves AstraZeneca's CALQUENCE (acalabrutinib) AstraZeneca Pharmaceuticals LP received FDA approval for CALQUENCE (acalabrutinib), an oral B...
AAPL
Is Siyata Mobile Walkie-ing The Talk-ie? Connecting People Around The World Via Next-Gen Mission-Critical Devices
Is Siyata Mobile Walkie-ing The Talk-ie? Connecting People Around The World Via Next-Gen Mission-Critical Devices...
AbbVie
FDA Approves SKYRIZI — AbbVie Inc.
AbbVie announced the FDA approval of risankizumab-RZAA (Skyrizi) for intravenous use, a formulation that may broaden the biologic’s market presence al...
SYTA
Are New Communication Products Like The SD7 Poised To Give A Significant Boost To The Push-To-Talk Market?
Are New Communication Products Like The SD7 Poised To Give A Significant Boost To The Push-To-Talk Market?...
Eugia
FDA Approves LEUPROLIDE ACETATE — Eugia US LLC
# FDA Approves Eugia US LLC's Generic Leuprolide Acetate Eugia US LLC received FDA approval for its generic leuprolide acetate formulation, marking a...
Aurobindo
FDA Approves VIGABATRIN — Aurobindo Pharma Limited
# FDA Approves Aurobindo Pharma's Generic Vigabatrin, Expanding Treatment Options for Seizure Disorders The FDA has approved Aurobindo Pharma Limited...
Teva
FDA Approves POMALIDOMIDE — Teva Pharmaceuticals, Inc.
# FDA Approves Generic Version of Pomalidomide; Teva Gains Market Entry Teva Pharmaceuticals, Inc. received FDA approval for its generic oral pomalid...
LUPIN
FDA Approves Unknown Drug — LUPIN LTD
# FDA Approves Lupin Ltd's Generic Drug Application Lupin Ltd has received FDA approval for generic drug application ANDA091040, expanding the compan...
Solco
FDA Approves NEBIVOLOL — Solco Healthcare US, LLC
# FDA Approves Generic Nebivolol; Solco Healthcare Entry Expected to Intensify Competition in Beta-Blocker Market Solco Healthcare US, LLC received F...
Novartis
FDA Approves PLUVICTO — Novartis Pharmaceuticals Corporation
# FDA Approves Novartis's PLUVICTO for Prostate Cancer Treatment Novartis Pharmaceuticals Corporation received FDA approval for PLUVICTO (lutetium lu...
Mylan
FDA Approves METHYLPHENIDATE — Mylan Pharmaceuticals Inc.
Mylan Pharmaceuticals Inc. has secured FDA approval for its ANDA206497, granting market access to the transdermal form of methylphenidate, a critical ...
Eskayef
FDA Approves PREGABALIN — Eskayef Pharmaceuticals Limited
# FDA Approves Pregabalin Generic from Eskayef Pharmaceuticals Eskayef Pharmaceuticals Limited received FDA approval for its generic pregabalin oral ...
Sobi,
FDA Approves VONJO — Sobi, Inc.
Sobi, Inc. received FDA approval for VONJO (pacritinib) to treat adult patients with Philadelphia-negative myelofibrosis who have intolerant or refrac...
BluePoint
FDA Approves DIVALPROEX SODIUM — BluePoint Laboratories
# FDA Approves Generic Divalproex Sodium for BluePoint Laboratories BluePoint Laboratories has received FDA approval for its generic divalproex sodiu...
Apotex
FDA Approves BRIMONIDINE TARTRATE — Apotex Corp.
# FDA Approves Apotex's Generic Brimonidine Tartrate Ophthalmic Treatment Apotex Corp. received FDA approval for its generic brimonidine tartrate oph...
Genentech,
FDA Approves VABYSMO — Genentech, Inc.
# FDA Approves Genentech's VABYSMO for Retinal Disease Treatment Genentech has received FDA approval for VABYSMO (faricimab), a novel intravitreal in...
MYLAN
FDA Approves Unknown Drug — MYLAN
# FDA Approval Newswire Mylan received FDA approval for a generic drug application (ANDA210275) on January 26, 2022, positioning the company to captu...